You are here: Industry Insights > Dr Reddy

News List

Novartis India extends access to its medicines in India with Dr Reddy’s Laboratories ExpressPharma
February 14, 2022
Novartis India recently announced an exclusive sales and distribution agreement with Dr Reddy’s Laboratories for a few of its established medicines which include the Voveran range, the Calcium range and Methergine, Novartis notified via a statement.
Dr Reddy’s launches dimethyl fumarate DR capsules in US expresspharma
September 28, 2020
Dr Reddy’s Laboratories announced the launch of dimethyl fumarate delayed-release capsules, a therapeutic equivalent generic version of Tecfidera (dimethyl fumarate) delayed-release capsules, approved by the US Food and Drug Administration (USFDA).
Dr Reddy’s launches dexmedetomidine hydrochloride in 0.9% sodium chloride injection in US expresspharma
September 27, 2020
It is an alpha-adrenergic agonist indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting.
Dr Reddy’s launches OTC Olopatadine Hydrochloride Ophthalmic Solution in US expresspharma
September 18, 2020
They are indicated for the temporary relief of eye allergies like itchy eyes due to pollen, ragweed, grass, animal hair and dander.
Dr Reddy’s announces settlement of Revlimid capsules patent litigation with Celgene in US expresspharma
September 18, 2020
Celgene has agreed to provide Dr Reddy’s with a license to sell volume-limited amounts of generic lenalidomide capsules in the US beginning on a confidential date after March 2022 subject to regulatory approval.
Dr Reddy’s Laboratories launches Redyx (remdesivir) in India expresspharma
September 18, 2020
It is available in the strength of 100 mg vial.
Dr Reddy’s Laboratories launches Diclofenac Sodium Topical Gel in US for arthritis pain relief expresspharma
September 18, 2020
The company has partnered with Encube Ethicals to distribute this product in the market.
RDIF and Dr Reddy’s to partner for trials and supply of 100 mn Sputnik V vaccine doses to India expresspharma
September 17, 2020
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.
Dr Reddy’s Laboratories launches Fulvestrant Injection in US expresspharma
September 08, 2020
Fulvestrant is an estrogen receptor antagonist indicated for the treatment of HR-positive advanced breast cancer.
Dr Reddy’s Labs launch methylphenidate hydrochloride extended-release tablets USP in US expresspharma
September 04, 2020
It is indicated for treatment of ADHD in children six years of age and older, adolescents, and adults up to the age of 65.

Previous page 1 2 3 4 5 Next page